Fantastic NIAAA News workshop on the detection & prevention of ALD w/ many great minds/perspectives working on this issue

The 🌏 burden is enormous w/ many barriers to the limited treatment options we have

✨I feel hopeful for our future + am in the right space #livertwitter

Important collaborative session to help identify gaps and research needs in reducing alcohol liver disease burden. Please also note virtual option Marina Serper, MD, MS Ashwani Singal Thomas G. Cotter, MD MS Deepika Devuni MD

Join NIAAA from April 17-18, 2024, for a Workshop on Reducing Alcohol-associated #Liver Disease (ALD) Burden through Early Screening and Management in the General Population.
RSVP recommended - see the Zoom info & Agenda: go.nih.gov/CC2qp74

If you want to change behavior, show the data. So proud of Anahita Rabiee adding to evidence behind safety of naltrexone in cirrhosis.

Among 2940 patients with cirrhosis started on naltrexone for AUD, zero cases of DILI was identified!
#livertwitter

sciencedirect.com/science/articl…

Led by the patient-provider communication guru Jeremy Louissaint UTSW Gastroenterology Fellowship in collaboration with Hobbs & Cohen Lab

An important message: brief alcohol interventions are underutilized in noncirrhotic CLD & non-alcohol-associated cirrhosis

Need to improve awareness and intervention delivery

Thanks for highlighting!
Let us all work to ⬆️ use of brief alcohol interventions in routine clinical care!

Great teamwork: Jonathan Melendez Wei Zhang MD PHD Ahmad Anouti, MD Amit G Singal Thomas G. Cotter, MD MS et al!

🧵 Review Article: Key Issues as Wearable Digital Health Technologies Enter Clinical Care

Wearable digital health technologies (DHTs) are devices that record behavioral or physiological data for use in medical decision making about the wearer. 1/9

#DigitalHealth

🚨Substance Use Series Review🚨
Management of Alcohol-Associated liver disease and alcohol use disorder in liver #transplant candidates & recipients: Challenges & opportunities
by Pratima Sharma, MD et al

journals.lww.com/lt/abstract/99…

#livertwitter #liverX #livertransplant #alcoholusedisorder

‼️ Mobile apps are powerful tools to monitor symptoms and engage in treatment for patients with liver disease

✅ Our editorial with Elliot Tapper summarizes the mobile apps in liver disease and offers suggestions for the path forward Hepatology Communications

journals.lww.com/hepcomm/fullte…

Lot of excitement about the potential of AI and clinical decision support

But how they are implemented is central to effectiveness

Very few people have the foresight to involve clinicians in building these tools

One such person is Jin Ge

journals.lww.com/hepcomm/fullte…

Excited to share our latest research on the use of stigmatizing language on liver transplant center websites for Alcohol Associated Liver Disease. Our findings highlight the need for more patient-centered language to reduce stigma and improve care.

Now published in Gastroenterology ➡️Our previous preprint comparing the UC San Francisco #Versa OpenAI #LLM vs manual chart review for extraction of data elements from #HCC imaging reports.

We updated our study using gpt-4 and achieved a 93.4% overall accuracy!

doi.org/10.1053/j.gast…

It's a cannot-miss event, featuring international experts in ALD and public health!

Don't miss our next ALD SIG Webinar: Global Alcohol Use and Alcohol Associated Liver Disease: Impacts of the Covid 19 Pandemic
Date: Tuesday, January 9, 12:00 pm - 1:00 pm (EST)
#LiverTwitter
aasld.org/events-and-web…